Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) Revenue (2016 - 2025)

DarioHealth filings provide 12 years of Revenue readings, the most recent being $5.2 million for Q4 2025.

  • On a quarterly basis, Revenue fell 31.21% to $5.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.4 million, a 17.31% decrease, with the full-year FY2025 number at $22.4 million, down 17.31% from a year prior.
  • Revenue hit $5.2 million in Q4 2025 for DarioHealth, up from $5.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $8.1 million in Q1 2022 to a low of -$15.3 million in Q4 2022.
  • Median Revenue over the past 5 years was $5.9 million (2021), compared with a mean of $4.8 million.
  • Biggest five-year swings in Revenue: surged 194.4% in 2021 and later crashed 354.5% in 2022.
  • DarioHealth's Revenue stood at $6.0 million in 2021, then plummeted by 354.5% to -$15.3 million in 2022, then soared by 123.57% to $3.6 million in 2023, then skyrocketed by 110.29% to $7.6 million in 2024, then tumbled by 31.21% to $5.2 million in 2025.
  • The last three reported values for Revenue were $5.2 million (Q4 2025), $5.0 million (Q3 2025), and $5.4 million (Q2 2025) per Business Quant data.